Krystal Biotech Inc. (KRYS)
NASDAQ · Healthcare
Krystal Biotech Inc. Operating Income 2020–2025
Krystal Biotech Inc. annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Krystal Biotech Inc. operating income for the quarter ending March 31, 2026 was 53.7 M, a 48.41% increase year-over-year.
- Krystal Biotech Inc. operating income for the twelve months ending March 31, 2026 was 178.6 M.
- Krystal Biotech Inc. annual operating income for 2025 was 161.3 M, a 56.30% increase from 2024.
- Krystal Biotech Inc. annual operating income for 2024 was 103.2 M, a 206.14% decrease from 2023.
- Krystal Biotech Inc. annual operating income for 2023 was -97.2 M, a 19.11% decrease from 2022.
- Krystal Biotech Inc. annual operating income for 2022 was -120.2 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Krystal Biotech Inc. Operating Income — FAQ
Krystal Biotech Inc. (KRYS) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Krystal Biotech Inc.'s operating income?
Krystal Biotech Inc. (KRYS) reported operating income of $161M for fiscal 2025.
Where can I see KRYS's operating income history?
The chart and table above show Krystal Biotech Inc.'s operating income by year and by quarter, including the growth rate.